[Flat-panel detector-based computed tomography: accuracy of experimental growth rate assessment in pulmonary nodules].

Rofo

Institut für Röntgendiagnostik, Klinikum rechts der Isar der TU München, München.

Published: May 2004

Purpose: To determine the performance of an a-Si/CsJ flat-panel detector-based volumetric computed tomography (VCT) prototype in volumetry of synthetic nodules in a pulmonary phantom, and to assess VCT accuracy in the assessment of hypothetic tumor growth rates based on predefined tumor doubling times.

Methods: The true volumes of 50 synthetic nodules (diameter range = 1.36 - 5.34 mm) were determined and VCT volumetry was performed before and after isovolumetric deformation of the nodules. The percent measurement error (PMF) was calculated as the percent difference of the measured from the true volume. Based on the PMF, the minimum interval between two scans was determined that would be needed to depict tumor growth corresponding to the minimum number of required follow-up days (FUDs). Based on predefined tumor doubling times (VDT) FUDs were determined before and after nodule deformation.

Results: Measured volumes of undeformed and deformed nodules of 0.99 - 20.05 mm (3) differed significantly from corresponding true volumes (p = 0.002 - 0.004). The PMFs of these nodules significantly exceeded the values measured in larger nodules (p = 0.0001 - 0.0029). In addition, PMFs were significantly lower before than after deformation (1.33 - 7.14 % and 0.61 - 11.09 %, respectively; p = 0.002). For theoretical VDTs of 177 and 396 days, the calculated FUDs for detection of tumor growth were 19.1 and 42.7 days before deformation, and 30.2 and 67.6 days after deformation for nodules < 2 mm, respectively.

Conclusion: VCT allows for accurate volumetry of smallest pulmonary nodules and may become a valuable clinical tool for depiction of tumor growth of even small lesions within very short scan intervals.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2004-813020DOI Listing

Publication Analysis

Top Keywords

tumor growth
16
computed tomography
8
nodules
8
synthetic nodules
8
based predefined
8
predefined tumor
8
tumor doubling
8
true volumes
8
deformation nodules
8
days deformation
8

Similar Publications

Background Aims: The clinical translation of mesenchymal stromal cell secretome (MSC-S) has been challenging owing to a lack of appropriate methods in downstream processing. Dialysis is an age-old method of protein purification by the exchange of small molecules through a semi-permeable membrane. In this study, we investigated the potential of three forms of umbilical cord-derived MSC secretome (UC-MSC-S)-native (S), dialyzed (DS), and lyophilized (LDS)-for wound healing applications.

View Article and Find Full Text PDF

Designing an anticancer Pd(II) complex as poly(ADP-ribose) polymerase 1 inhibitor.

Int J Biol Macromol

January 2025

School of Biological and Food Engineering, Guangxi Science & Technology Normal University, Laibin, Guangxi 546199, China. Electronic address:

Targeting DNA repair mechanisms, particularly PARP-1 inhibition, has emerged as a promising strategy for developing anticancer therapies. we designed and synthesized two 2-thiazolecarboxaldehyde thiosemicarbazone palladium(II) complexes (C1 and C2), and evaluated their anti-cancer activities. These Pd(II) complexes exhibited potent PARP-1 enzyme inhibition and demonstrated considerable antiproliferative activity against various cancer cell lines.

View Article and Find Full Text PDF

STAT3 Orchestrates Immune Dynamics in Hepatocellular Carcinoma: A Pivotal Nexus in Tumor Progression.

Crit Rev Oncol Hematol

January 2025

Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Hubei Key Laboratory of Precision Radiation Oncology, Hubei, China.

Hepatocellular carcinoma (HCC) presents a formidable challenge in oncology, attributed to its association with chronic liver diseases and global prevalence. The immune microenvironment profoundly influences HCC progression, balancing immune suppression and antitumor responses. The Signal Transducer and Activator of Transcription 3 (STAT3) is central to this equilibrium, orchestrating immune dynamics and intertwining tumor progression with immune evasion mechanisms.

View Article and Find Full Text PDF

Design and synthesis of isatin derivative payloaded peptide-drug conjugate as tubulin inhibitor against colorectal cancer.

Eur J Med Chem

January 2025

China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, Tianjin University of Science and Technology, Tianjin, 300457, China. Electronic address:

A series of isatin derivatives which could inhibit colorectal cancer (CRC) were synthesized. Among those compounds, 5B exhibited good inhibitory activity of CRC through the inhibition of tubulin expression, inducing apoptosis, and causing G2/M phase cell cycle arrest pathway, which suggested that 5B could be a potential tubulin inhibitor. Based on that, a novel peptide-drug conjugate (PDC), which employed the CRC cells related receptor CD44 ligand peptide A6 coupling to 5B to accomplish A6-5B.

View Article and Find Full Text PDF

Estrogen receptor (ER) is a direct and reciprocal target gene for GATA3. Previous studies have shown that higher GATA3 expression in primary breast cancer (BC) is associated with a reduced probability of developing lung metastasis when compared to those with metastatic recurrence to other organs. Further, GATA3 downregulates several genes promoting BC lung metastasis and upregulates genes encoding known inhibitors of lung metastasis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!